• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down2.84% Nasdaq Down2.94%

    More On GEVA

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    Financials

    • Income Statement
    • Balance Sheet
    • Cash Flow

    Synageva BioPharma Corp. (GEVA)

    -NasdaqGS
    238.60 0.00(0.00%) Jun 22, 3:59PM EDT
    Add to Portfolio
    Company EventsGet Company Events for:
    Upcoming Events 
    DateEventReminder
    No Upcoming Events
    Recent Events 
    DateEvent
    23-Jun-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Notice of Delisting o
    6-May-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Amendments to Articles of Inc
    30-Apr-15SYNAGEVA BIOPHARMA CORP Files SEC form 10-Q, Quarterly Report
    29-Apr-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    26-Feb-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    9-Feb-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
    2-Feb-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement
    7-Jan-15SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Other Events, Financial Statements and Exhibits
    30-Oct-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E
    22-Sep-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib
    9-Sep-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Change in Directors or Principal Officers
    31-Jul-14SYNAGEVA BIOPHARMA CORP Files SEC form 10-Q, Quarterly Report
    30-Jul-14SYNAGEVA BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E